[Therapeutic trial with azo-Wintomylon in acute urinary infections].
D000208:Acute Disease; D000293:Adolescent; D000328:Adult; D000892:Anti-Infective Agents, Urinary / Q000009:adverse effects / Q000627:therapeutic use*; D001391:Azo Compounds / Q000009:adverse effects / Q000627:therapeutic use*; D002648:Child; D005069:Evaluation Studies as Topic; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009268:Nalidixic Acid / Q000627:therapeutic use*; D011725:Pyridines / Q000009:adverse effects / Q000627:therapeutic use*; D014552:Urinary Tract Infections / Q000188:drug therapy*
D000892:Anti-Infective Agents, Urinary; D001391:Azo Compounds; D011725:Pyridines; D009268:Nalidixic Acid
Ensao terapéutico con azo-Wintomylon en infecciones urinarias agudas.